Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

How should patients with unstable angina and non-ST-segment elevation myocardial infarction be managed? A meta-analysis of randomized trials.

Choudhry NK, Singh JM, Barolet A, Tomlinson GA, Detsky AS.

Am J Med. 2005 May;118(5):465-74. Review.

PMID:
15866246
2.
3.

Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data.

Fox KA, Clayton TC, Damman P, Pocock SJ, de Winter RJ, Tijssen JG, Lagerqvist B, Wallentin L; FIR Collaboration.

J Am Coll Cardiol. 2010 Jun 1;55(22):2435-45. doi: 10.1016/j.jacc.2010.03.007. Epub 2010 Mar 30. Review.

4.

Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era.

Fanning JP, Nyong J, Scott IA, Aroney CN, Walters DL.

Cochrane Database Syst Rev. 2016 May 26;(5):CD004815. doi: 10.1002/14651858.CD004815.pub4. Review.

PMID:
27226069
5.

Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era.

Hoenig MR, Doust JA, Aroney CN, Scott IA.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004815. Review. Update in: Cochrane Database Syst Rev. 2010;(3):CD004815.

PMID:
16856061
6.
7.

Interpreting new treatment guidelines for non-ST-segment elevation acute coronary syndromes.

Boden WE.

Am J Cardiol. 2001 Oct 18;88(8A):19K-24K. Review.

PMID:
11694215
9.

Early vs. delayed invasive strategy in patients with acute coronary syndromes without ST-segment elevation: a meta-analysis of randomized studies.

Navarese EP, De Servi S, Gibson CM, Buffon A, Castriota F, Kubica J, Petronio AS, Andreotti F, De Luca G.

QJM. 2011 Mar;104(3):193-200. doi: 10.1093/qjmed/hcq258. Epub 2011 Jan 23. Review.

PMID:
21262739
10.
11.

Early invasive versus conservative strategies for unstable angina and non-ST elevation myocardial infarction in the stent era.

Hoenig MR, Aroney CN, Scott IA.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD004815. doi: 10.1002/14651858.CD004815.pub3. Review. Update in: Cochrane Database Syst Rev. 2016;(5):CD004815.

PMID:
20238333
12.

Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.

Piscione F, Piccolo R, Cassese S, Galasso G, Chiariello M.

Catheter Cardiovasc Interv. 2009 Aug 1;74(2):323-32. doi: 10.1002/ccd.22017. Review.

PMID:
19360858
16.
17.

Risk stratification in non-ST segment elevation acute coronary syndromes with special focus on recent guidelines.

Mathis AS, Meswani P, Spinler SA.

Pharmacotherapy. 2001 Aug;21(8):954-87. Review.

PMID:
11718501
18.

Unstable angina and non-ST-elevation myocardial infarction: initial antithrombotic therapy and early invasive strategy.

Cannon CP, Turpie AG.

Circulation. 2003 Jun 3;107(21):2640-5. Review. No abstract available.

19.

Effects of age on long-term outcomes after a routine invasive or selective invasive strategy in patients presenting with non-ST segment elevation acute coronary syndromes: a collaborative analysis of individual data from the FRISC II - ICTUS - RITA-3 (FIR) trials.

Damman P, Clayton T, Wallentin L, Lagerqvist B, Fox KA, Hirsch A, Windhausen F, Swahn E, Pocock SJ, Tijssen JG, de Winter RJ.

Heart. 2012 Feb;98(3):207-13. doi: 10.1136/heartjnl-2011-300453. Epub 2011 Sep 19. Review.

PMID:
21930723
20.

Early invasive compared with a selective invasive strategy in women with non-ST-elevation acute coronary syndromes: a substudy of the OASIS 5 trial and a meta-analysis of previous randomized trials.

Swahn E, Alfredsson J, Afzal R, Budaj A, Chrolavicius S, Fox K, Jolly S, Mehta SR, de Winter R, Yusuf S.

Eur Heart J. 2012 Jan;33(1):51-60. doi: 10.1093/eurheartj/ehp009. Epub 2009 Feb 7. Review.

PMID:
19202154

Supplemental Content

Support Center